Attend Pittcon 2025 in Boston to connect with global leaders in laboratory science and explore cutting-edge advancements in ...

Vertex (VERX – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Chris Quintero from ...

Vertex, Inc. ( (VERX)) has released its Q3 earnings. Here is a breakdown of the information Vertex, Inc. presented to its investors. Vertex, Inc., a prominent player in the indirect tax solutions ...

Q3 2024 Earnings Call Transcript November 6, 2024 Operator: Good day, and welcome to the Vertex Inc. Third Quarter 2024 ...

Vertex Pharmaceuticals has a virtual monopoly in treating cystic fibrosis, having created and brought to market a function cure for 90% of the CF population. Their pipeline outside of CF has shown ...

Vertex Pharmaceuticals is in the process of getting a new painkiller approved. It just published some data that suggests the candidate will be quite profitable. But regulators still need to sign ...

Vertex has reported phase 3 data on its near-approval pain drug candidate suzetrigine, shedding light on how the non-opioid painkiller combines with ibuprofen and why the prospect failed to match ...

But there was one company that kept at it. Fast-forward to today, and Vertex Pharmaceuticals is on the verge of gaining an FDA approval for suzetrigine (VX-548), a nonaddictive oral treatment that ...

Prince William County Public Schools is weighing options for the 2025-26 academic calendar after division leaders presented ...

The 2025-26 academic calendar also scheduled many single day breaks, including for three-day weekends, and over two weeks off for the winter break.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The countdown to the holiday season has begun, and what better way to build anticipation, delight and a little daily treat than with an adult advent calendar? Gone are the days of bland chocolates ...